While these approaches produce results, they come with significant costs, downtime, and in the case of surgery, inherent risks
Graf M.V., Lorez H.P., Gillessen D., Tobler H.I., Schoenenberger G.A
Conclusion In conclusion, this study reveals that excessive GSH intake may contribute to chemotherapy resistance in breast cancer patients, identifying high GSH intake as an independent risk factor for tumor recurrence
This compounded preparation: Has not been approved by the FDA Has not undergone FDA review for safety, effectiveness, or quality Is prepared specifically for you based on your prescriber's order Individual outcomes may vary Dosing is determined by the prescribing provider based on patient-specific factors
Pract Neurol